Armstrong Shaw Associates’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-9,409
| Closed | -$1.26M | – | 41 |
|
|
2018
Q4 | $1.26M | Sell |
9,409
-257
| -3% | -$34.4K | 1.31% | 26 |
|
|
2018
Q3 | $1.84M | Sell |
9,666
-145
| -1% | -$27.6K | 1.58% | 25 |
|
|
2018
Q2 | $1.64M | Sell |
9,811
-1,817
| -16% | -$303K | 1.48% | 27 |
|
|
2018
Q1 | $1.96M | Buy |
11,628
+201
| +2% | +$33.8K | 1.77% | 26 |
|
|
2017
Q4 | $1.87M | Sell |
11,427
-454
| -4% | -$74.3K | 1.58% | 28 |
|
|
2017
Q3 | $2.44M | Sell |
11,881
-16,637
| -58% | -$3.41M | 2.2% | 25 |
|
|
2017
Q2 | $6.93M | Sell |
28,518
-15,914
| -36% | -$3.87M | 2.61% | 23 |
|
|
2017
Q1 | $10.6M | Sell |
44,432
-2,716
| -6% | -$649K | 2.65% | 22 |
|
|
2016
Q4 | $9.9M | Sell |
47,148
-2,938
| -6% | -$617K | 2.35% | 25 |
|
|
2016
Q3 | $11.5M | Buy |
+50,086
| New | +$11.5M | 2.87% | 20 |
|